Inhibitor Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2014 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Inhibitor Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2014 to Q4 2022.
  • Inhibitor Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2022 was $3.36K.
  • Inhibitor Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2022 was $23.2K.
  • Inhibitor Therapeutics, Inc. annual Interest Expense for 2022 was $23.2K, a 56.6% increase from 2021.
  • Inhibitor Therapeutics, Inc. annual Interest Expense for 2021 was $14.8K.
  • Inhibitor Therapeutics, Inc. annual Interest Expense for 2014 was $37.5K, a 1849% increase from 2013.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $23.2K $3.36K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $7.71K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $6.76K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $5.41K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2014 $37.5K $950 Oct 1, 2014 Dec 31, 2014 10-K 2016-02-01
Q3 2014 $1.98K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $25K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $9.56K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.